JPRN-UMIN000029781已完成未知
Efficacy and safety of glecaprevir and pibrentasvir in chronic hepatitis C patients with hemodialysis - Efficacy of glecaprevir and pibrentasvir in chronic hepatitis C patients with hemodialysis
kitasato University school of medicine0 个研究点目标入组 50 人开始时间: 2017年11月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Decompensated cirrhosis, Liver failure (2)patients with hepatic cell carcinoma (3) Co-infection with hepatitis B virus Co-infection with anti- humanimmunodeficiency virus
研究者
相似试验
尚未招募
不适用
Efficacy and safety of Glecaprevir/Pibrentasvir plus Ribavirin in Patients who failed Direct-acting antivirals; DAAs with chronic hepatitis Cchronic hepatitis CJPRN-UMIN000031615Tokai University10
已完成
不适用
Efficacy and safety of glecaprevir/pibrentasvir combination tablets for patients infected with pan-genotypic hepatitis C virusChronic Hepatitis CJPRN-UMIN000029652Saitama Medical University200
已完成
不适用
Safety and efficacy of glecaprevir/pibrentasvir combination therapy for hepatitis C infected patients with chronic hepatitis or liver cirrhosisJPRN-UMIN000031090Hokkaido University Hospital300
已完成
不适用
Safety and efficacy of glecaprevir/pibrentasvir combination therapy for hemodialysis patients with genotype 2 hepatitis C infectioJPRN-UMIN000036099Hokkaido University Hospital40
已完成
不适用
Safety and efficacy of Glecaprevir / Pibrentasvir combination therapy for chronic hepatitis C - including hemodialysis patientsPatients with chronic hepatitis C patients and patients with type C compensated cirrhosisJPRN-UMIN000032073ippon Medical School Chiba Hokusoh Hospital1,200